Melasma is not a failure of discipline but a chronicle written in skin — a chronic condition shaped by sun, heat, hormones, genetics, and the ambient glow of modern screens. Dermatologist Cláudia Magalhães reminds us that the body's pigment-producing systems respond to triggers far beyond what most people anticipate, and that treatment without understanding those triggers is like bailing water without finding the leak. The condition cannot be erased, only negotiated — and that negotiation demands consistency, medical guidance, and a honest reckoning with daily habits.
Melasma não tem cura: entenda por que manchas retornam mesmo com tratamento
Cobertura Relacionada
Simone Mendes apresentou show na madrugada de quinta-feira (27) no Palco Estádio da Festa do Peão de Barretos, animando …
G1 · Aug 27 Influenciadora esfaqueia suspeito de abusar da filha em Franca; caso é investigadoInfluenciadora de 25 anos feriu com canivete homem acusado de abusar sexualmente da filha de 5 anos em Franca, SP. Políc…
G1 · Aug 27 Vereador preso por crimes sexuais recorre ao STF para recuperar salário de R$ 18,5 milVereador de Piracicaba preso desde dezembro de 2025 e acusado de crimes sexuais contra 12 mulheres recorre ao STF para r…
G1 · Aug 27 Cirurgião de empresária morta na BA enfrentou denúncias de pacientes em 2023Cirurgião plástico responsável pela morte de empresária em Ilhéus havia sido denunciado por pacientes em 2023 por compli…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
Article discusses melasma, a chronic skin condition; no geopolitical implications identified.
Lente Económico
Melasma is a chronic incurable skin condition; dermatological treatments and skincare products create ongoing consumer demand for management solutions despite lack of permanent cure.
Consumers face recurring treatment costs for melasma management without cure prospects, driving sustained demand for preventive products (sunscreen, protective cosmetics) and professional dermatological services. Awareness of screen light exposure may increase demand for blue-light blocking products.
Healthcare systems may need to address melasma management in dermatology coverage; cosmetics regulation may require clearer labeling about incurable conditions; public health campaigns could emphasize prevention (sun protection, metabolic health) to reduce treatment burden.